Results

Beam Therapeutics Inc.

11/12/2021 | Press release | Distributed by Public on 11/12/2021 06:09

Beam Therapeutics Reports Preclinical Data Highlighting Multiplex Base Editing Approach to Create Anti-CD5 CAR T-cell Investigational Therapies for T-Cell Malignancies